Cult Australian suncare brand debuts Unblock Screen™ SPF 50, the first US sunscreen formulated with Bemotrizinol (BEMT), approved by the FDA in June 2026 NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Ultra Violette, the cult Australian suncare brand known…
- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada. - Global Phase III clinical program to investigate efficacy and safety of three maintenance doses…
The association's Boston Coaching Partners roster grows to three — adding an executive and career coach who helps high-performing women lead with clarity, confidence, and authenticity without sacrificing themselves in the processBOSTON, Aug. 29, 2026 /PRNewswire/ -- The…
Expanded BPO services strengthen Incuvio Health's ability to support healthcare organizations through technology-enabled operational excellence, clinical expertise, and scalable workforce solutions. LOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- Incuvio Health today announced the expansion of its Business Process…
At a Glance:New Autism Center Location: 500 S. Kraemer Blvd, Suite 100B, Brea, CA 92821 – in North Orange County, near the 57 and 90 freewaysWho It Serves: Toddlers and young children with autism spectrum disorder (ASD) under…
CEPI backs Minapharm's Bundibugyo ebolavirus vaccine candidate, based on ProBioGen's proprietary MVA-CR19 platformOSLO, Norway, CAIRO and BERLIN, Aug. 27, 2026 /PRNewswire/ -- Leading African biopharmaceutical company Minapharm Group, headquartered in Egypt with subsidiaries in Berlin, will receive up to…
TAIPEI, Aug. 26, 2026 /PRNewswire/ -- Exascend announced the successful deployment of its Medical-Grade Storage Solutions in collaboration with a leading healthcare technology provider, supporting the demanding requirements of next-generation medical systems. The enterprise-grade solution delivers reliable performance, data…
Published in Critical Care Medicine, findings confirm high-predictive accuracy for severe sepsis outcomes, driving commercial momentum across Volition's $2.8 billion addressable market.HENDERSON, Nev., Aug. 26, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company,…
Paves the Way to Launch its Second Innovative Drug Directly in the U.S.Announces agreement to in-license near-commercial candidate at a press conferenceTargets U.S. commercial launch as early as 2029… Upfront and milestone payments related to the Kv7 platform…
SEOUL, South Korea, Aug. 25, 2026 /PRNewswire/ -- Leading experts from around the globe are convening to examine what new scientific discoveries could mean for the millions of people living with movement disorders. The International Congress of Parkinson's…